Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

TheraTech, Palatin collaborate on oral peptides; first product will be a new treatment for ED

April 2, 1998

BioTime files NDA for blood plasma volume expander

April 2, 1998

New compounds synthesized at HMR upregulate LDL receptors

April 2, 1998

New diaminoguanidine for diabetes presented by Pharmacia & Upjohn

April 1, 1998

Zenarestat potentially useful for both NIDDM- and IDDM-associated neuropathy

April 1, 1998

Novel therapies for type II diabetes disclosed by HMR

April 1, 1998

Bayer investigates CETP inhibitors as hypolipidemic/antiatherosclerotic agents

April 1, 1998

Novel antiosteoporotic compound discovered by AHP

April 1, 1998

Novo Nordisk concludes Japanese agreement for levormeloxifene

March 31, 1998

Kissei presents promising new agent for premature labor

March 31, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...